{
    "clinical_study": {
        "@rank": "58642", 
        "acronym": "T\u00e9AGS", 
        "arm_group": [
            {
                "arm_group_label": "methylprednisolone", 
                "arm_group_type": "Active Comparator", 
                "description": "administration of 60 mg of methylprednisolone at 8:00 am and 100 ml of 0.9 % sodium chloride (placebo) at 6:00 pm"
            }, 
            {
                "arm_group_label": "Ketoprofen", 
                "arm_group_type": "Active Comparator", 
                "description": "administration of 100 mg of ketoprofen at 8:00 am and at 6:00 pm"
            }, 
            {
                "arm_group_label": "sodium chloride", 
                "arm_group_type": "Placebo Comparator", 
                "description": "administration of 100 ml of 0.9%  sodium chloride (placebo) at 8:00 am and at 6:00 pm"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether anti-inflammatory drugs or glucocorticoids\n      are effective in the treatment of acute sciatica"
        }, 
        "brief_title": "Safety and Efficacy of Nonsteroidal Antiinflammatory (NSAI)Drug and Glucocorticoids in Acute Sciatica", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sciatica", 
        "condition_browse": {
            "mesh_term": "Sciatica"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  sciatica <8 weeks resistant to all treatments in ambulatory\n\n          -  Acute low back pain> 48 hours;\n\n          -  Non-deficit patients;\n\n          -  Initial VAS> 40/100;\n\n          -  Consent of patient\n\n          -  Conflict disco-radicular concordance with the clinical computed tomography scan or\n             magnetic resonance imaging.\n\n          -  No of contraindications to methylprednisolone, ketoprofen;\n\n          -  No registration to another protocol;\n\n        Exclusion Criteria:\n\n          -  Pregnant, parturient, lactating mother;\n\n          -  Diabetic patient;\n\n          -  Patient with syndrome from narrowing of the lumbar vertebral canal\n\n          -  Patient with a history of lumbar surgery <1 year;\n\n          -  Patient with a Cauda equina syndrome or major motor disability;\n\n          -  Crural neuralgia\n\n          -  Patient with a deficit;\n\n          -  Suspicion of sciatica secondary, ie not conflict-related disco-root: infectious\n             neuritis, fracture on spinal bone tumor ...\n\n        associated treatment or pathology contra-indicating administration methylprednisolone,\n        ketoprofen."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "144", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01816334", 
            "org_study_id": "1201"
        }, 
        "intervention": [
            {
                "arm_group_label": "methylprednisolone", 
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Ketoprofen", 
                "intervention_name": "Ketoprofen", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "methylprednisolone", 
                    "sodium chloride"
                ], 
                "intervention_name": "Sodium Chloride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Anti-Inflammatory Agents", 
                "Ketoprofen", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Anti-Inflammatory Agents, Non-Steroidal", 
                "Glucocorticoids", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sciatica", 
            "Anti-Inflammatory Agents, Non-Steroidal", 
            "Glucocorticoids"
        ], 
        "lastchanged_date": "March 19, 2013", 
        "location": [
            {
                "contact": {
                    "email": "mdurand1@chu-grenoble.fr", 
                    "last_name": "DURAND"
                }, 
                "facility": {
                    "address": {
                        "city": "Echirolles", 
                        "country": "France", 
                        "zip": "38130"
                    }, 
                    "name": "CHU H\u00f4pital Sud"
                }, 
                "investigator": [
                    {
                        "last_name": "Robert JUVIN, MD PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Anne Sudre, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Athan Baillet, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mdurand1@chu-grenoble.fr", 
                    "last_name": "DURAND"
                }, 
                "facility": {
                    "address": {
                        "city": "Uriage", 
                        "country": "France", 
                        "zip": "38410"
                    }, 
                    "name": "CH d'Uriage"
                }, 
                "investigator": {
                    "last_name": "Sylvie GROS CLAUDE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "3", 
        "official_title": "Safety and Efficacy of Nonsteroidal Antiinflammatory Drug and Glucocorticoids in Acute Sciatica", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "VAS is measured in millimiters (0 to 100). This pain score is recommended in rheumatologic units in France.", 
            "measure": "Mean visual analogue scale (VAS) for leg pain (radicular pain) in 3 groups", 
            "safety_issue": "No", 
            "time_frame": "From day 0 to day 5"
        }, 
        "reference": [
            {
                "PMID": "21525139", 
                "citation": "Roncoroni C, Baillet A, Durand M, Gaudin P, Juvin R. Efficacy and tolerance of systemic steroids in sciatica: a systematic review and meta-analysis. Rheumatology (Oxford). 2011 Sep;50(9):1603-11. doi: 10.1093/rheumatology/ker151. Epub 2011 Apr 27. Review."
            }, 
            {
                "PMID": "17909211", 
                "citation": "Chou R, Huffman LH; American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med. 2007 Oct 2;147(7):505-14. Review. Erratum in: Ann Intern Med. 2008 Feb 5;148(3):247-8."
            }, 
            {
                "PMID": "11132976", 
                "citation": "Vroomen PC, de Krom MC, Slofstra PD, Knottnerus JA. Conservative treatment of sciatica: a systematic review. J Spinal Disord. 2000 Dec;13(6):463-9."
            }, 
            {
                "PMID": "9165992", 
                "citation": "Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis. 1997 Apr;56(4):214-23. Review."
            }, 
            {
                "PMID": "17415595", 
                "citation": "Luijsterburg PA, Verhagen AP, Ostelo RW, van Os TA, Peul WC, Koes BW. Effectiveness of conservative treatments for the lumbosacral radicular syndrome: a systematic review. Eur Spine J. 2007 Jul;16(7):881-99. Epub 2007 Apr 6. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01816334"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "VAS is measured in millimeters (0 to 100).", 
                "measure": "Mean visual analogue scale (VAS) for back pain in 3 groups", 
                "safety_issue": "No", 
                "time_frame": "From day 0 to day 5"
            }, 
            {
                "description": "Drug compliance is estimated based on the proportion of the treatment actually administered.", 
                "measure": "Assess drug compliance", 
                "safety_issue": "No", 
                "time_frame": "From day 0 to day 5"
            }, 
            {
                "description": "The EIFEL questionnaire is the translation of the Roland Morris Disability Questionnaire (RMDQ) and has been validated in acute low back pain.", 
                "measure": "The effect of treatment on the EIFEL Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "At baseline, 1 and 3 months after intervention"
            }, 
            {
                "description": "Lasegue's sign is the lumbar pain experienced by the patient on passive movement of the legs during flexion of hip joint i.e. passive straight leg raising. It is assessed as either 'Positive' or 'Negative' sign.", 
                "measure": "Improvement in Lasegue's sign compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "At baseline, Day 1,2,3,4 and 5 of study period"
            }, 
            {
                "description": "Schober's test is a test used in rheumatology to measure the ability of  patient to flex their lower back", 
                "measure": "Assess Schober's test", 
                "safety_issue": "No", 
                "time_frame": "From Day 0 to Day 5"
            }, 
            {
                "description": "Analgesic consumption between active treatment group and placebo group was registered and differences between groups were calculated and presented as percentual differences.", 
                "measure": "Analgesic consumption", 
                "safety_issue": "No", 
                "time_frame": "At baseline, day 0, 1, 2, 3, 4 and day 5, 1 and 3 months"
            }, 
            {
                "description": "Number of patient having surgery and/or lumbar epidural injection during study period", 
                "measure": "Surgery or lumbar epidural injection", 
                "safety_issue": "No", 
                "time_frame": "At 1 and 3 months after intervention"
            }, 
            {
                "description": "Number of adverse events and/or high blood pressure between intervention group.", 
                "measure": "Clinical tolerance: adverse events and/or high blood pressure", 
                "safety_issue": "No", 
                "time_frame": "at baseline, day 1, 2 3, 4 and 5"
            }, 
            {
                "description": "measures of leukocytes, erythrocytes, hemoglobin, platelets, serum sodium, potassium, glucose, plasma creatinine between intervention group", 
                "measure": "Biological tolerance", 
                "safety_issue": "No", 
                "time_frame": "at baseline, day 3 and 5"
            }, 
            {
                "description": "monitoring of glycemic status is measured for each day of treatment", 
                "measure": "Glycemic levels", 
                "safety_issue": "No", 
                "time_frame": "at baseline, day 1 to 5"
            }, 
            {
                "description": "To assess the cost of sciatica for society", 
                "measure": "Number of days of hospitalisation sick leave, number of days lost to illness", 
                "safety_issue": "No", 
                "time_frame": "At baseline, 1 and 3 months"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}